Skip to main content

Featured

More HZMB private car quotas set

The governments of Hong Kong and Macau have agreed to increase the regular quotas for Hong Kong cross-boundary non-commercial private cars using the Hong Kong-Zhuhai-Macao Bridge to Macau, the Transport Department announced today.   The decision was made to enhance traffic flow between Hong Kong and Macau, better utilising the bridge, the department said.   It will increase the Hong Kong quota by 1,000, following the earlier quota allocation of 1,800 for Hong Kong.   The additional quota will be distributed in two phases from the second quarter.   Half of the additional 1,000 quota allocations is for company applicants and the other half is for individual applicants. The quotas are valid for no more than three years. The eligibility criteria of quota applications remains the same.   Private cars allocated with Hong Kong quotas will be permitted to access the city of Macau multiple times using the bridge.   The Hong Kong quota allotments will be re-allocated upon expiry thro

Myocarditis after jab reported

The Department of Health today said it received from the Hospital Authority a total of three reports of suspected myocarditis for adolescents who have received BioNTech vaccines up to July 19 and their conditions were stable.   In response to media enquiries, the department noted around 63,000 doses of BioNTech vaccines have been administered to adolescents aged 12 to 15 in the same period.   The three cases involved one 12-year-old and two 15-year-old boys. They complained of chest pain about two days after receiving the second dose of BioNTech vaccine.   They were all admitted to the authority's hospitals for monitoring and treatment, and their conditions were stable.   These cases will be passed to the Expert Committee on Clinical Events Assessment Following COVID-19 Immunization for causality assessment.   The expert committee noted that there were reports from overseas drug regulatory authorities about cases of myocarditis and pericarditis following vaccination, especially among younger vaccine recipients.   The committee has endorsed the inclusion of myocarditis and pericarditis in the list of serious or unexpected adverse events following immunisation to enhance monitoring.   The department has also been closely monitoring adverse events of myocarditis or pericarditis among adolescents of 12 to 15 years old.   According to the BioNTech vaccine manufacturer, cases of myocarditis and pericarditis have primarily occurred within 14 days following vaccination, more often after the second vaccination and in younger men.   The supplier has also updated the product's package insert to include myocarditis and pericarditis as its adverse reactions.   The department reminded adolescents and young adults to avoid strenuous exercise for one week after vaccination.   They should seek immediate medical attention if they develop symptoms indicative of myocarditis or pericarditis such as acute and persisting chest pain, shortness of breath or palpitations following vaccination.
http://dlvr.it/S45Jlq

Popular Posts